Guidance document : fees for the right to sell drugs.: H13-9/13-2018E-PDF
"This document provides guidance on the interpretation of the Fees in Respect of Drugs and Medical Devices Regulations (Fee Regulations) with a focus on how the Fees for the Right to Sell Drugs, contained in Part 2, Division 4 of these regulations, will be administered"--Introd., p. 7.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.856866&sl=0
| Department/Agency | Canada. Health Canada. |
|---|---|
| Title | Guidance document : fees for the right to sell drugs. |
| Variant title | Fees for the right to sell drugs |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Later edition | Guidance document : |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Ligne directrice : frais à payer le droit de vendre une drogue. Cover title. "Date adopted: 1998/05. Revised date: 2018/06/13. Effective date: 2018/06/13." "Publication date: June 2018." Issued also in HTML format. |
| Publishing information | Ottawa : Health Canada, 2018. |
| Description | 15 p. |
| ISBN | 9780660266626 |
| Catalogue number |
|
| Departmental catalogue number | 180095 |
| Subject terms | Pharmaceutical industry Retail trade Government policy |